Search

Licheng Tr Shi

from Moraga, CA
Age ~60
Get Report
Also known as:
Licheng I Shi, Li Cheng Shi, Li-Cheng Shi, Licheng Zhang, Cheng Shi Li, Shi Licheng
Related to:
Li Xiao, 34Yu Chen, 59Zi J Li, 44Shan Li, 43Yu Chen, 54
Connected to:
Ashley H Shi, 46Chang L Shi, 62Chen S Shi, 42Chong T Shi, 68Cynthia M Shi, 29Danling Shi, 68Danni Shi, 45Di J Shi, 74Frances Shi, 52Ho S Shi, 57

Licheng Shi Phones & Addresses

  • Moraga, CA
  • Temecula, CA
  • 18 Redwood Tree Ln, Irvine, CA 92612
  • 5243 Via Capote, Newbury Park, CA 91320 (805) 358-2725
  • Riverside, CA

Work

Company: Amgen Position: Scientist

Education

School / High School: China Medical University (Tw) 1981 to 1986 Specialities: Medicine

Skills

Drug Development • Biopharmaceuticals • Assay Development • Pharmaceutical Industry • Drug Discovery

Industries

Biotechnology

Resumes

Resumes

Licheng Shi Photo 1

Senior Scientific Researcher

View page
Location:
82 Sanders Ranch Rd, Moraga, CA 94556
Industry:
Biotechnology
Work:
Amgen
Scientist
Education:
China Medical University (Tw) 1981 - 1986
Skills:
Drug Development
Biopharmaceuticals
Assay Development
Pharmaceutical Industry
Drug Discovery

Publications

Us Patents

Glaucoma Treatments With Reduced Hyperpigmentation

View page
US Patent:
20030018078, Jan 23, 2003
Filed:
Jun 26, 2001
Appl. No.:
09/893159
Inventors:
David Woodward - Lake Forest CA, US
Licheng Shi - Irvine CA, US
Achim Krauss - Foothill Ranch CA, US
Clayton Spada - Fullerton CA, US
Sheila Mac Neil - Sheffield, GB
Linda Smith-Thomas - Sheffield, GB
Assignee:
Allergan Sales, Inc.
International Classification:
A61K031/557
C12Q001/00
US Classification:
514/573000, 435/004000
Abstract:
Methods to identify agents having ocular hypotensive activity which have reduced or absent ability to stimulate iridial hyperpigmentation are disclosed. The methods reside in part in detecting the ability of a test compound to interact with the FP receptor.

Human Cgrp Receptor Binding Proteins

View page
US Patent:
20100172895, Jul 8, 2010
Filed:
Dec 18, 2009
Appl. No.:
12/642711
Inventors:
Thomas C. Boone - Newbury Park CA, US
David W. Brankow - Northridge CA, US
Chadwick T. King - N. Vancouver, CA
Hsieng Sen Lu - Westlake Village CA, US
Licheng Shi - Newbury Park CA, US
Cen Xu - Newbury Park CA, US
International Classification:
A61K 39/395
C12P 21/00
C12N 5/10
C12N 5/00
C07K 2/00
C07K 16/00
C07H 21/04
US Classification:
4241301, 435 696, 435325, 435358, 435364, 435366, 4353201, 530300, 5303871, 5303873, 5303881, 536 2353
Abstract:
Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches.

Human Cgrp Receptor Binding Proteins

View page
US Patent:
20130071410, Mar 21, 2013
Filed:
Sep 12, 2012
Appl. No.:
13/612615
Inventors:
Thomas C. Boone - Newbury Park CA, US
David W. Brankow - Northridge CA, US
Chadwick T. King - Vancouver, CA
Hsieng Sen Lu - Westlake Village CA, US
Licheng Shi - Newbury Park CA, US
Cen Xu - Newbury Park CA, US
International Classification:
A61K 39/395
C12N 15/13
C07H 21/04
A61P 25/00
C12P 21/02
C12N 15/63
C12N 1/21
C12N 1/19
C12N 5/10
C07K 16/28
A61P 25/06
US Classification:
4241721, 5303891, 5303879, 5303873, 536 2353, 53038822, 4353201, 43525233, 4352542, 435331, 435 696
Abstract:
Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related, disorders including the treatment and/or prevention of migraine headaches.

Human Cgrp Receptor Binding Proteins

View page
US Patent:
20180142029, May 24, 2018
Filed:
Nov 28, 2017
Appl. No.:
15/824827
Inventors:
- Thousand Oaks CA, US
David W. BRANKOW - Northridge CA, US
Chadwick T. KING - North Vancouver, CA
Hsieng Sen LU - Westlake Village CA, US
Licheng SHI - Newbury Park CA, US
Cen XU - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07K 16/28
A61K 39/395
A61K 39/00
Abstract:
Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches.

Human Cgrp Receptor Binding Proteins

View page
US Patent:
20150376286, Dec 31, 2015
Filed:
Jun 26, 2015
Appl. No.:
14/752493
Inventors:
- Thousand Oaks CA, US
David W. BRANKOW - Northridge CA, US
Chadwick T. KING - North Vancouver, CA
Hsieng Sen LU - Westlake Village CA, US
Licheng SHI - Newbury Park CA, US
Cen XU - Newbury Park CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07K 16/28
Abstract:
Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches.
Control profile
Licheng Tr Shi from Moraga, CA, age ~60 Get Report